-
1دورية أكاديمية
المؤلفون: Venkatakrishnan, K, Ecsedy, JA
المصدر: Clinical Pharmacology & Therapeutics; Jan2017, Vol. 101 Issue 1, p99-113, 15p
مصطلحات موضوعية: ANTINEOPLASTIC agents, DRUG development, ONCOLOGY, PHARMACODYNAMICS, PHARMACOLOGY
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Owonikoko TK; Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: towonik@emory.edu., Niu H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Nackaerts K; KU Leuven, Universitaire Ziekenhuizen, Leuven, Belgium., Csoszi T; Hetenyi G Korhaz, Szolnok, Hungary., Ostoros G; Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Hungary., Mark Z; Tudogyogyintezet Torokbalint, Torokbalint, Hungary., Baik C; University of Washington Seattle Cancer Care Alliance, Seattle, Washington., Joy AA; University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada., Chouaid C; CHI de Créteil, Créteil, France., Jaime JC; Hospital Universitario Virgen del Rocio, Seville, Spain., Kolek V; Fakultni Nemocnice Olomouc, Olomouc, Czech Republic., Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Roubec J; Fakultni Nemocnice Ostrava, Ostrava Poruba, Czech Republic., Santos ES; Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida., Chiang AC; Yale University School of Medicine, New Haven, Connecticut., Speranza G; Université de Sherbrooke, Centre intégré de cancérologie de la Montéregie, Hôpital Charles Le Moyne, Greenfield Park, Quebec City, Canada., Belani CP; Penn State Cancer Institute, Hershey, Pennsylvania., Chiappori A; H. Lee Moffitt Cancer Center, Tampa, Florida., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida., Czebe K; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Byers L; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Bahamon B; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Li C; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Sheldon-Waniga E; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Kong EF; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Williams M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Badola S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Shin H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bedford L; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ecsedy JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bryant M; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Jones S; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Simmons J; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Leonard EJ; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ullmann CD; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Spigel DR; Personal Genome Diagnostics, Baltimore, Maryland.
مؤلفون مشاركون: C14018 study investigators
المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Feb; Vol. 15 (2), pp. 274-287. Date of Electronic Publication: 2019 Oct 23.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Paclitaxel*, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Azepines ; Biomarkers ; Disease-Free Survival ; Double-Blind Method ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Pyrimidines ; Retrospective Studies ; Treatment Outcome
-
10دورية أكاديمية
المؤلفون: Currier MA; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Sprague L; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Rizvi TA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Nartker B; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Chen CY; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Wang PY; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Hutzen BJ; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Franczek MR; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Patel AV; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Chaney KE; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Streby KA; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.; Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Ecsedy JA; Takeda Pharmaceuticals International Co, Cambridge, MA, USA., Conner J; Virttu Biologics, Ltd, Biocity, Scotland, Newhouse, United Kingdom., Ratner N; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio, USA., Cripe TP; Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.; Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.
المصدر: Oncotarget [Oncotarget] 2017 Mar 14; Vol. 8 (11), pp. 17412-17427.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Azepines/*administration & dosage , Neurilemmoma/*pathology , Neuroblastoma/*pathology , Oncolytic Virotherapy/*methods , Pyrimidines/*administration & dosage, Animals ; Aurora Kinase A/antagonists & inhibitors ; Blotting, Western ; Cell Line, Tumor ; Combined Modality Therapy ; Cytotoxicity, Immunologic/immunology ; Female ; Flow Cytometry ; Herpesvirus 1, Human ; Humans ; Immunity, Innate/immunology ; Immunohistochemistry ; Mice ; Mice, Nude ; Xenograft Model Antitumor Assays